We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+36.08%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+531.4%
AUM
$4.08B
AUM Growth
+$236M
Cap. Flow
-$708M
Cap. Flow %
-17.33%
Top 10 Hldgs %
19.32%
Holding
5,845
New
765
Increased
1,967
Reduced
2,395
Closed
667

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.65%
2 Technology 23.8%
3 Financials 7.62%
4 Industrials 7.22%
5 Healthcare 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNPS icon
301
Synopsys
SNPS
$81.6B
$2.28M 0.06%
5,106
-1,569
-24% -$738K
COF icon
302
Capital One
COF
$123B
$2.27M 0.06%
11,325
-26,361
-70% -$5.04M
T icon
303
AT&T
T
$174B
$2.26M 0.06%
109,304
-8,688
-7% -$216K
ILMN icon
304
Illumina
ILMN
$40.8B
$2.26M 0.06%
12,857
+7,915
+160% +$1.16M
PPL
305
PPL Corp
PPL
$24.1B
$2.26M 0.06%
62,092
+21,379
+53% +$790K
BWXT icon
306
BWX Technologies
BWXT
$12.7B
$2.25M 0.06%
11,575
+7,594
+191% +$1.58M
VRSK icon
307
Verisk Analytics
VRSK
$22B
$2.23M 0.05%
12,445
+902
+8% +$159K
APLD icon
308
Applied Digital
APLD
$7.46B
$2.23M 0.05%
59,833
+7,831
+15% +$302K
WBD icon
309
Warner Bros
WBD
$77.4B
$2.23M 0.05%
83,702
-176,391
-68% -$4.77M
COP icon
310
ConocoPhillips
COP
$153B
$2.23M 0.05%
21,425
-1,917
-8% -$227K
IHE icon
311
iShares US Pharmaceuticals ETF
IHE
$1.68B
$2.22M 0.05%
+22,455
New +$2.02M
CTAS icon
312
Cintas
CTAS
$79.9B
$2.22M 0.05%
13,046
-33,119
-72% -$5.73M
SBUX icon
313
Starbucks
SBUX
$108B
$2.22M 0.05%
21,693
-76,039
-78% -$7.66M
SPCX
314
SpaceX
SPCX
$1.96T
$2.2M 0.05%
+12,890
New +$2.19M
WSM icon
315
Williams-Sonoma
WSM
$27.3B
$2.2M 0.05%
9,419
+8,367
+795% +$1.66M
VZ icon
316
Verizon
VZ
$196B
$2.18M 0.05%
51,411
-56,688
-52% -$2.66M
FANG icon
317
Diamondback Energy
FANG
$52.3B
$2.17M 0.05%
12,356
-11,821
-49% -$2.29M
SEIX icon
318
Virtus SEIX Senior Loan ETF
SEIX
$258M
$2.17M 0.05%
93,615
-98,727
-51% -$2.29M
PH icon
319
Parker-Hannifin
PH
$123B
$2.15M 0.05%
2,201
-2,611
-54% -$2.39M
ABNB icon
320
Airbnb
ABNB
$92.8B
$2.15M 0.05%
15,034
+3,038
+25% +$414K
BKNG icon
321
Booking.com
BKNG
$123B
$2.15M 0.05%
12,061
-50,814
-81% -$8.67M
SO icon
322
Southern Company
SO
$95.3B
$2.14M 0.05%
22,321
-8,422
-27% -$793K
XEL icon
323
Xcel Energy
XEL
$43.6B
$2.14M 0.05%
26,599
-14,195
-35% -$1.13M
VRTX icon
324
Vertex Pharmaceuticals
VRTX
$133B
$2.13M 0.05%
4,292
-9,612
-69% -$4.26M
ESGU icon
325
iShares ESG Aware MSCI USA ETF
ESGU
$18.2B
$2.13M 0.05%
+13,017
New +$2.06M

Similar funds

Tower Research Capital (TRC)'s Q2 2026 Portfolio in Review

As of Q2 2026, Tower Research Capital (TRC) held 5,845 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) withdrew a net $708M in Q2 2026, closing 667 positions and reducing 2,395 holdings. Its most notable exit was iShares MSCI USA Min Vol Factor ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $84M.

  • Tower Research Capital (TRC)'s largest Q2 2026 buy was iShares Core S&P 500 ETF: 112,156 shares worth $84M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $130M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $361M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2026, selling an estimated $13M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $4.08B portfolio in Q2 2026.
  • Tower Research Capital (TRC) opened 765 new positions and closed 667 in Q2 2026.
  • Tower Research Capital (TRC)'s portfolio value rose 6.1% quarter-over-quarter to $4.08B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.